Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T39901 |
PROTAC IRAK4 degrader-4
PROTAC IRAK4 degrader-4 |
||
PROTAC IRAK4 degrader-4 (US20190192668A1, compound I-127) is a Cereblon-based PROTAC specifically designed to target and degrade interleukin-1 receptor-associated kinase 4 (IRAK4). | |||
T39902 |
PROTAC IRAK4 degrader-5
PROTAC IRAK4 degrader-5 |
||
PROTAC IRAK4 degrader-5 is a Cereblon-based IRAK4 degrader. | |||
T39903 |
PROTAC IRAK4 degrader-6
PROTAC IRAK4 degrader-6 |
||
PROTAC IRAK4 degrader-6 is a potent Cereblon-based compound designed to degrade interleukin-1 receptor-associated kinase 4 (IRAK4). | |||
T39920 |
PROTAC IRAK4 degrader-3
PROTAC IRAK4 degrader-3 |
PROTACs | PROTAC |
PROTAC IRAK4 degrader-3 is a PROTAC-induced IRAK4 degrader based on von Hippel-Lindau. | |||
T13842 |
PROTAC IRAK4 degrader-1
|
Others; PROTACs | Others; PROTAC |
PROTAC IRAK4 degrader-1 is a degrader of PROTAC interleukin-1 receptor-associated kinase 4 (IRAK4). | |||
T7755 |
Thalidomide 4-fluoride
E3 ligase Ligand 4,2-(2,6-二氧代-哌啶-3-基)-4-氟基-异吲哚-1,3-二酮 |
IRAK; Ligand for E3 Ligase | Immunology/Inflammation; NF-κB; PROTAC |
Thalidomide 4-fluoride (E3 ligase Ligand 4) 是一种基于 Thalidomide 的 Cereblon 配体,可用于募集 CRBN 蛋白。它能够利用 linker 与 IRAK4 靶蛋白配体连接,得到 PROTAC IRAK4 degrader-1。 |